Annual Working Capital
$304.60 M
+$28.25 M+10.22%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual working capital is currently $304.60 million, with the most recent change of +$28.25 million (+10.22%) on 31 December 2023. During the last 3 years, it has fallen by -$113.67 million (-27.18%). ARCT annual working capital is now -27.18% below its all-time high of $418.27 million, reached on 31 December 2020.ARCT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$261.36 M
+$6.07 M+2.38%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly working capital is currently $261.36 million, with the most recent change of +$6.07 million (+2.38%) on 30 September 2024. Over the past year, it has dropped by -$44.23 million (-14.47%). ARCT quarterly working capital is now -37.51% below its all-time high of $418.27 million, reached on 31 December 2020.ARCT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | -14.5% |
| 3 y3 years | -27.2% | -13.7% |
| 5 y5 years | +941.3% | +352.8% |
ARCT Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -27.2% | +10.2% | -21.9% | +53.0% |
| 5 y | 5 years | -27.2% | +941.3% | -37.5% | +520.7% |
| alltime | all time | -27.2% | >+9999.0% | -37.5% | >+9999.0% |
Arcturus Therapeutics Holdings Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $261.36 M(+2.4%) |
| June 2024 | - | $255.29 M(-1.9%) |
| Mar 2024 | - | $260.36 M(-14.5%) |
| Dec 2023 | $304.60 M(+10.2%) | $304.60 M(-0.3%) |
| Sept 2023 | - | $305.58 M(+3.6%) |
| June 2023 | - | $294.90 M(-11.8%) |
| Mar 2023 | - | $334.43 M(+21.0%) |
| Dec 2022 | $276.35 M(-1.1%) | $276.35 M(+61.8%) |
| Sept 2022 | - | $170.83 M(-14.1%) |
| June 2022 | - | $198.76 M(-9.5%) |
| Mar 2022 | - | $219.70 M(-21.4%) |
| Dec 2021 | $279.42 M(-33.2%) | $279.42 M(-7.7%) |
| Sept 2021 | - | $302.73 M(-17.6%) |
| June 2021 | - | $367.27 M(-11.9%) |
| Mar 2021 | - | $416.66 M(-0.4%) |
| Dec 2020 | $418.27 M(+689.7%) | $418.27 M(+46.2%) |
| Sept 2020 | - | $286.09 M(+140.5%) |
| June 2020 | - | $118.95 M(+182.5%) |
| Mar 2020 | - | $42.11 M(-20.5%) |
| Dec 2019 | $52.97 M(+81.1%) | $52.97 M(-8.2%) |
| Sept 2019 | - | $57.72 M(+23.0%) |
| June 2019 | - | $46.92 M(+113.3%) |
| Mar 2019 | - | $21.99 M(-24.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $29.25 M(-26.6%) | $29.25 M(+40.6%) |
| Sept 2018 | - | $20.80 M(-11.2%) |
| June 2018 | - | $23.43 M(-41.2%) |
| Dec 2017 | $39.83 M(+1007.3%) | $39.83 M(+4.5%) |
| Sept 2017 | - | $38.11 M(-5.8%) |
| June 2017 | - | $40.46 M(-8.0%) |
| Mar 2017 | - | $43.98 M(+1122.8%) |
| Dec 2016 | $3.60 M(-92.8%) | $3.60 M(-92.7%) |
| Sept 2016 | - | $49.33 M(-4.1%) |
| June 2016 | - | $51.45 M(-2.3%) |
| Mar 2016 | - | $52.65 M(+5.3%) |
| Dec 2015 | $49.99 M(+153.1%) | $49.99 M(+43.7%) |
| Sept 2015 | - | $34.80 M(-9.8%) |
| June 2015 | - | $38.56 M(+95.2%) |
| Dec 2014 | $19.75 M(-59.3%) | $19.75 M(-23.3%) |
| Sept 2014 | - | $25.75 M(-26.9%) |
| June 2014 | - | $35.21 M(-16.3%) |
| Mar 2014 | - | $42.07 M(-13.4%) |
| Dec 2013 | $48.58 M(-8362.2%) | $48.58 M(+163.4%) |
| Sept 2013 | - | $18.44 M(-13.6%) |
| June 2013 | - | $21.34 M(-3728.7%) |
| Dec 2012 | -$588.00 K(-231.3%) | -$588.00 K |
| Dec 2011 | $448.00 K | - |
FAQ
- What is Arcturus Therapeutics Holdings annual working capital?
- What is the all time high annual working capital for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual working capital year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly working capital?
- What is the all time high quarterly working capital for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly working capital year-on-year change?
What is Arcturus Therapeutics Holdings annual working capital?
The current annual working capital of ARCT is $304.60 M
What is the all time high annual working capital for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual working capital is $418.27 M
What is Arcturus Therapeutics Holdings annual working capital year-on-year change?
Over the past year, ARCT annual working capital has changed by +$28.25 M (+10.22%)
What is Arcturus Therapeutics Holdings quarterly working capital?
The current quarterly working capital of ARCT is $261.36 M
What is the all time high quarterly working capital for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly working capital is $418.27 M
What is Arcturus Therapeutics Holdings quarterly working capital year-on-year change?
Over the past year, ARCT quarterly working capital has changed by -$44.23 M (-14.47%)